Fmoc-D-Asp-OH,
136083-57-3,
Fmoc-D-aspartic acid,
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-aspartic Acid,
N-Fmoc-D-aspartic Acid,
(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)butanedioic acid,
C19H17NO6,
PubChem10504,
D-Aspartic acid,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-,
SCHEMBL1486199,
CTK8B0465,
KS-00000YXN,
DTXSID60426525,
ZINC2244302,
ANW-20009,
CF-171,
MFCD01318740,
AKOS015840857,
AB08736,
AM81589,
RTR-004848,
AC-17110,
AJ-34464,
AN-31955,
DS-15024,
TR-004848,
F0592,
FT-0643250,
ST24047246,
083F573,
J-300073,
Q-101797,
(R)-2-(((9H-FLUOREN-9-YL)METHOXY)CARBONYLAMINO)SUCCINIC ACID,
(2R)-2-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}butanedioic acid, AldrichCPR,
Fmoc-Asp-OH,
Fmoc-L-Asp-OH,
N-Fmoc-L-aspartic Acid,
CB10151,
CID7006674,
Fmoc-D-Asp-OH, 98% - 1G 1g,
A7369,
2-(9H-fluoren-9-ylmethoxycarbonylamino)butanedioic Acid,
119062-05-4,
D-Aspartic acid, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-; (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)succinic acid,